Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-22T05:07:07.257Z Has data issue: false hasContentIssue false
  • English
  • Français

Cerebrospinal fluid somatostatin in delirium

Published online by Cambridge University Press:  09 July 2009

Hannu Koponen ,
Ulla Stenbäck ,
Esa Mattila ,
Kari Reinikainen ,
Hilkka Soininen  and
Paavo J. Riekkinen
Hannu Koponen*
Affiliation:
Department of Neurology, University Central Hospital of Kuopio, SF-70210 Kuopio and Moisio Hospital, SF-50520 Mikkeli, Finland
Ulla Stenbäck
Affiliation:
Department of Neurology, University Central Hospital of Kuopio, SF-70210 Kuopio and Moisio Hospital, SF-50520 Mikkeli, Finland
Esa Mattila
Affiliation:
Department of Neurology, University Central Hospital of Kuopio, SF-70210 Kuopio and Moisio Hospital, SF-50520 Mikkeli, Finland
Kari Reinikainen
Affiliation:
Department of Neurology, University Central Hospital of Kuopio, SF-70210 Kuopio and Moisio Hospital, SF-50520 Mikkeli, Finland
Hilkka Soininen
Affiliation:
Department of Neurology, University Central Hospital of Kuopio, SF-70210 Kuopio and Moisio Hospital, SF-50520 Mikkeli, Finland
Paavo J. Riekkinen
Affiliation:
Department of Neurology, University Central Hospital of Kuopio, SF-70210 Kuopio and Moisio Hospital, SF-50520 Mikkeli, Finland
*
1Address for correspondence: Dr Hannu Koponen, Kirkkokatu 33 B 26, SF-70100 Kuopio, Finland.
Get access Rights & Permissions [Opens in a new window]

Synopsis

Cerebrospinal fluid somatostatin-like immunoreactivity (CSF SLI) was determined for 67 elderly patients who met the DSM-III criteria for delirium and for 19 age-matched controls. As a group, and also when subdivided according to the type of delirium, severity of cognitive decline or the type of central nervous system disease, the delirious patients showed significant reductions of SLI compared with the controls, together with a declining trend associated with increasing cognitive dysfunction. These findings are in accordance with previous observations that reduced CSF SLI is associated with diseases in which cognitive function is disturbed and they extend this finding to delirium.

Type
Original Articles
Information
Psychological Medicine , Volume 19 , Issue 3 , August 1989 , pp. 605 - 609
Copyright
Copyright © Cambridge University Press 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (1980). Diagnostic and Statistical Manual of Mental Disorders (3rd edn). APA: Washington, D.C.Google Scholar
Aronin, N.Cooper, P. E., Lorentz, L. J., Bird, E. D., Sagar, S. M., Leeman, S. E. & Martin, J. B. (1983). Somatostatin is increased in the basal ganglia in Huntington disease. Annals of Neurology 13, 519–526.CrossRefGoogle ScholarPubMed
Beal, M. F., Martin, J. B. (1986). Neuropeptides in neurological disease. Annals of Neurology 20, 547–565.CrossRefGoogle ScholarPubMed
Beal, M. F., Bird, E. D., Langlais, P. J. & Martin, J. B. (1984). Somatostatin is increased in the nucleus accumbens in Huntington's disease. Neurology 34, 663–666.CrossRefGoogle ScholarPubMed
Beal, M. F., Mazurek, M. F., Black, P. McL. & Martin, J. B. (1985). Human cerebrospinal fluid somatostatin in neurologic disease. Journal of the Neurological Sciences 71, 91–104.CrossRefGoogle ScholarPubMed
Beal, M. F., Growdon, J. H., Mazurek, M. F. & Martin, J. B. (1986). CSF somatostatin-like immunoreactivity in dementia. Neurology 36, 294–297.CrossRefGoogle ScholarPubMed
Bissette, G., Widerlöv, E., Walleus, H., Karlsson, I., Eklund, K., Loosen, P. T. & Nemeroff, C. B. (1986). Alterations in cerebrospinal fluid concentrations of somatostatin-like immunoreactivity in neuropsychiatric disorders. Archives of General Psychiatry 43, 1148–1151.CrossRefGoogle ScholarPubMed
Cramer, H., Schaudt, D., Rissler, K., Strubel, D., Warter, J.-M. & Kuntzman, F. (1985 a). Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus. Journal of Neurology 232, 346–351.CrossRefGoogle ScholarPubMed
Cramer, H., Wolf, A., Rissler, K., Weigel, K. & Ostertag, C. (1985 b). Ventricular somatostatin-like immunoreactivity in patients with basal ganglia disease. Journal of Neurology 232, 219–222.CrossRefGoogle ScholarPubMed
Davies, P. & Terry, R. D. (1981). Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type. Neurobiology of Aging 2, 9–14.CrossRefGoogle ScholarPubMed
Davies, P., Katzman, R. & Terry, D. R. (1980). Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature 288, 279–280.CrossRefGoogle Scholar
Dupont, E., Christensen, S. E, Hansen, A. P., Olivarius, B. F. & Orskov, H. (1982). Low cerebrospinal fluid somatostatin in Parkinson disease: an irreversible abnormality. Neurology 32, 312–314.CrossRefGoogle ScholarPubMed
Epelbaum, J., Ruberg, M., Moyse, E., Javoy-Agid, F., Dubois, B. & Agid, Y. (1983). Somatostatin and dementia in Parkinson's disease. Brain Research 278, 376–379.CrossRefGoogle ScholarPubMed
Ferrier, I. N., Cross, A. J., Johnson, J. A., Roberts, G. W., Crow, T. J., Corsellis, J. A. N., Lee, Y. C., O'Shaugnessy, D., Adrian, T. E., McGregor, G. P., Baracese-Hamilton, A. J. & Bloom, S. R. (1983). Neuropeptides in Alzheimer type dementia. Journal of the Neurological Sciences 62, 159–170.CrossRefGoogle ScholarPubMed
Folstein, M. F., Folstein, S. E. & McHugh, P. R. (1975). ‘Minimental state’ A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12, 189–198.CrossRefGoogle Scholar
Francis, P. T., Bowen, D. M., Neary, D., Palo, J., Wikström, J. & Olney, J., (1984). Somatostatin-like immunoreactivity in lumbar cerebrospinal fluid from neurohistologically examined demented patients. Neurobiology of Aging 5, 183–186.CrossRefGoogle ScholarPubMed
Garcia-Sevilla, J., Magnusson, T. & Carlsson, A. (1978). Effect of intracerebroventricularly administrated somatostatin on brain monoamine turnover. Brain Research 155, 159–164.CrossRefGoogle ScholarPubMed
Hachinski, V. C., Iliff, L. D., Zihlka, E., DuBoulay, G. H., McAllister, V. L., Marshall, J., Russell, R. W. R. & Symon, L. (1982). Cerebral blood flow in dementia. Archives of Neurology 32, 632–637.CrossRefGoogle Scholar
Hökfelt, T., Johansson, O., Ljungdahl, A., Lundberg, J M. & Schulzberg, M. (1980). Peptidergic neurons. Nature 284, 515–521.CrossRefGoogle Scholar
Hughes, C. P., Berg, L., Danziger, W. L., Coben, L. A. & Martin, R. L. (1982). A new clinical scale for the staging of dementia. British Journal of Psychiatry 140, 566–572.CrossRefGoogle ScholarPubMed
Jolkkonen, J., Soininen, H., Halonen, T., Ylinen, A., Laulumaa, V., Laakso, M. & Reikkinen, P. J. (1986). Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia. Journal of Neurology, Neurosurgery and Psychiatry 49, 1374–1377.CrossRefGoogle ScholarPubMed
Kowall, N. W. & Beal, M. F. (1988). Cortical somatostatin, neuropeptide Y, and NADPH neurons: normal anatomy and alterations in Alzheimer's disease. Annals of Neurology 23, 105–114.CrossRefGoogle ScholarPubMed
Lipowski, Z. J. (1980). Delirium: Acute Brain Failure in Man. Charles C. Thomas: Springfield.Google Scholar
Lipowski, Z. J. (1983). Transient cognitive disorders (delirium, acute confusional states) in the elderly. American Journal of Psychiatry 140, 1426–1436.Google ScholarPubMed
Lipowski, Z. J. (1984). Acute confusional states in the elderly. In Clinical Neurology of Aging (ed. Albert, M. L.), pp. 277–297. Oxford University Press: New York.Google Scholar
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. & Stadlan, E. M. (1984). Clinical diagnosis of Alzeimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939–944.CrossRefGoogle Scholar
Patel, Y. C., Rao, K. & Reichlin, K. (1977). Somatostatin in human cerebrospinal fluid. New England Journal of Medicine 296, 529–533.CrossRefGoogle ScholarPubMed
Rabins, P. V. & Folstein, M. F. (1982). Delirium and dementia: diagnostic criteria and fatality rates. British Journal of Psychiatry 140, 149–153.CrossRefGoogle ScholarPubMed
Reinikainen, K. J., Riekkinen, P. J., Jolkkonen, J., Kosma, V.-M. & Soininen, H. (1987). Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease. Brain Research 402, 103–108.CrossRefGoogle ScholarPubMed
Rossor, M. N., Emson, P. C., Mountjoy, C. Q., Roth, M. & Iversen, L. L. (1980). Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type. Neuroscience Letters 20, 373–377.CrossRefGoogle ScholarPubMed
Rubinow, D. R., Gold, P. W., Post, R. M., Ballenger, J. C., Cowdry, R., Bollinger, J. & Reichlin, S. (1983). CSF somatostalin in affective illness. Archives of General Psychiatry 40, 409–412.CrossRefGoogle ScholarPubMed
Soininen, H. S., Jolkkonen, J. T., Reinikainen, K. J., Halonen, T. O. & Riekkinen, P. J. (1984). Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of Alzheimer type. Journal of the Neurological Sciences 63, 167–172.CrossRefGoogle Scholar
Sörensen, K. V., Christensen, S. E., Hansen, A. P, Ingerslev, J., Pedersen, E. & Orskov, H. (1981). The origin of cerebrospinal fluid somatostatin: hypothalamic or disperse central nervous system secretion. Neuroendocrinology 32, 335–338.CrossRefGoogle ScholarPubMed
Sulkava, R. & Amberla, K. (1982). Alzheimer's disease and senile dementia of Alzheimer's type: a neuropsychological study. Acta Neurologica Scandinavica 65, 651–660.CrossRefGoogle ScholarPubMed
Tamminga, C. A., Foster, N. L., Fedio, P., Bird, E. D. & Chase, T. N. (1987). Alzheimer's disease: low cerebral somatostatin levels correlate with impaired cognitive function and cortical metabolism. Neurology 37 161–165.CrossRefGoogle ScholarPubMed
Thal, L. J., Sharpless, N. S., Rosenbaum, D., Davies, P., Amin, I. T. & Waltz, J. M. (1985). Ventricular fluid somatostatin concentrations decrease in childhood-onset dystonia. Neurology 35, 1742–1746.CrossRefGoogle ScholarPubMed
Woodhams, P L., Roberts, G. W., Polak, J. M. & Crow, T. J. (1983). Distribution of neuropeptides in the limbic system of the rat: the bed nucleus of the stria terminalis, septum and preoptic area. Neuroscience 8, 677–703.CrossRefGoogle ScholarPubMed